Andrew S Hyatt
Overview
Explore the profile of Andrew S Hyatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mahal B, Ziehr D, Hyatt A, Neubauer-Sugar E, OFarrell D, OLeary M, et al.
Brachytherapy
. 2014 Jun;
13(5):442-9.
PMID: 24880584
Background: Salvage brachytherapy in patients with prior pelvic radiation carries a risk of rectal injury. Herein, we report our initial experience using a hydrogel spacer between the prostate and the...
12.
Mahal B, Ziehr D, Aizer A, Hyatt A, Lago-Hernandez C, Choueiri T, et al.
J Geriatr Oncol
. 2014 May;
5(4):352-8.
PMID: 24862107
Purpose: To evaluate the relationship between age and race on the receipt of definitive therapy among men with high-risk prostate cancer (CaP). Methods: We used the Surveillance, Epidemiology and End...
13.
Mahal B, Aizer A, Ziehr D, Hyatt A, Choueiri T, Hu J, et al.
Clin Genitourin Cancer
. 2014 May;
12(5):e189-95.
PMID: 24861952
Background: Men with low-risk prostate cancer (CaP) are considered unlikely to die of CaP and have the option of active surveillance. This study evaluated whether African American (AA) men who...
14.
Mahal B, Ziehr D, Aizer A, Hyatt A, Sammon J, Schmid M, et al.
Urol Oncol
. 2014 May;
32(8):1285-91.
PMID: 24846344
Objectives: Treating high-risk prostate cancer (CaP) with definitive therapy improves survival. We evaluated whether having health insurance reduces racial disparities in the use of definitive therapy for high-risk CaP. Materials...
15.
Seible D, Gu X, Hyatt A, Beard C, Choueiri T, Efstathiou J, et al.
Urology
. 2014 Apr;
83(6):1316-21.
PMID: 24726149
Objective: To identify factors associated with weight gain at 1 year from initiation of androgen deprivation therapy (ADT). Methods: A retrospective review assessed weight change among 118 men with nonmetastatic...
16.
Nguyen P, Hyatt A, Devlin P
Oncology (Williston Park)
. 2013 Dec;
27(10):980, 982.
PMID: 24367854
No abstract available.